BSXBoston Scientific
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. 10-K, Item 1
- Employees
- 59,000
- Headquarters
- Marlborough, MA
- CEO
- Michael F. Mahoney
- Next results
- around Feb 3, 2027
The numbers BSX said it expected, in its earnings releases of the last 3 years, next to what it then reported for the same period. Each target links to the sentence in the release; each result to the 10-Q or 10-K it was first reported in.
| Target | What the company said | Reported | Result |
|---|---|---|---|
| Diluted EPS Q4 of fiscal 2025 |
Given $1.97 to $2.01 release 2025-10-22
|
– | Not found in XBRL |
The company's wordsGuidance for Full Year and Fourth Quarter 2025 … The company estimates EPS on a GAAP basis in a range of $1.97 to $2.01 and estimates adjusted EPS, excluding certain charges (credits), of $3.02 to $3.04. release 2025-10-22 | |||
| Diluted EPS Q4 of fiscal 2024 |
Given $1.28 to $1.30 release 2024-10-23
|
– | Not found in XBRL |
The company's wordsGuidance for Full Year and Fourth Quarter 2024 … The company estimates EPS on a GAAP basis in a range of $1.28 to $1.30 and estimates adjusted EPS, excluding certain charges (credits), of $2.45 to $2.47. release 2024-10-23 | |||
6 targets far from the company's reported total, so not compared (usually a target for one product, segment or definition)
- Diluted EPS, Q3 of fiscal 2025: said $1.89 to $1.93, reported $0.51. The company's words
- Diluted EPS, Q2 of fiscal 2025: said $1.86 to $1.93, reported $0.53. The company's words
- Diluted EPS, Q1 of fiscal 2025: said $1.86 to $1.93, reported $0.45. The company's words
- Diluted EPS, Q3 of fiscal 2024: said $1.34 to $1.38, reported $0.32. The company's words
- Diluted EPS, Q2 of fiscal 2024: said $1.43 to $1.48, reported $0.22. The company's words
- Diluted EPS, Q1 of fiscal 2024: said $1.38 to $1.42, reported $0.33. The company's words
Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (12 releases since 2024-01-31), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.
Work on BSX in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/BSX/export.csv") into a cell.